CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Operating activities
Net income	$ 822,726	$ 814,958
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	178,156	166,805
Deferred income tax provision	(9,890)	(5,826)
Impairment, closure costs, and asset disposals	11,056	9,917
Provision for credit losses	(1,247)	(155)
Stock-based compensation expense	75,150	81,243
Other	7,622	4,511
Changes in operating assets and liabilities:
Accounts receivable	39,946	18,331
Inventory	8,493	3,763
Prepaid expenses and other current assets	(3,606)	20,348
Operating lease assets	150,957	135,881
Other assets	(362)	1,769
Accounts payable	12,360	7,802
Accrued payroll and benefits	(24,689)	(4,438)
Accrued liabilities	2,126	17,056
Unearned revenue	(25,555)	(22,260)
Income tax payable/receivable	(13,433)	(18,565)
Operating lease liabilities	(113,450)	(101,348)
Other long-term liabilities	2,042	2,020
Net cash provided by operating activities	1,118,402	1,131,812
Investing activities
Purchases of leasehold improvements, property and equipment	(305,395)	(273,193)
Purchases of investments	(6,500)	(738,434)
Maturities of investments	319,962	374,373
Net cash provided by/(used in) investing activities	8,067	(637,254)
Financing activities
Repurchase of common stock	(997,055)	(172,368)
Tax withholding on stock-based compensation awards	(33,319)	(73,011)
Other financing activities	1,540	(29)
Net cash used in financing activities	(1,028,834)	(245,408)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(786)	(1,121)
Net change in cash, cash equivalents, and restricted cash	96,849	248,029
Cash, cash equivalents, and restricted cash at beginning of period	778,379	586,163
Cash, cash equivalents, and restricted cash at end of period	875,228	834,192
Supplemental disclosures of cash flow information
Income taxes paid	279,327	277,427
Purchases of leasehold improvements, property and equipment accrued in accounts payable and accrued liabilities	75,585	76,304
Repurchase of common stock accrued in accounts payable and accrued liabilities	$ 9,016	$ 9,803